2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …

PA Heidenreich, B Bozkurt, D Aguilar, LA Allen… - Journal of the American …, 2022 - jacc.org
Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Multimodality imaging assessment of myocardial fibrosis

S Gupta, Y Ge, A Singh, C Gräni, RY Kwong - Cardiovascular Imaging, 2021 - jacc.org
Myocardial fibrosis, seen in ischemic and nonischemic cardiomyopathies, is associated with
adverse cardiac outcomes. Noninvasive imaging plays a key role in early identification and …

2022 ACC/AHA/HFSA guideline for the management of heart failure

PA Heidenreich, B Bozkurt, D Aguilar, LA Allen… - Journal of Cardiac …, 2022 - Elsevier
ABSTRACT Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

T1 map** and extracellular volume fraction in dilated cardiomyopathy: a prognosis study

S Li, D Zhou, A Sirajuddin, J He, J Xu, B Zhuang… - Cardiovascular …, 2022 - jacc.org
Objectives The aim of this study is to examine the prognostic value of T1 map** and the
extracellular volume (ECV) fraction in patients with dilated cardiomyopathy (DCM) …

Risk Stratification in Nonischemic Dilated Cardiomyopathy Using CMR Imaging: a systematic review and meta-analysis

C Eichhorn, D Koeckerling, RK Reddy, M Ardissino… - Jama, 2024 - jamanetwork.com
Importance Accurate risk stratification of nonischemic dilated cardiomyopathy (NIDCM)
remains challenging. Objective To evaluate the association of cardiac magnetic resonance …

Empagliflozin reduces myocardial extracellular volume in patients with type 2 diabetes and coronary artery disease

T Mason, OR Coelho-Filho, S Verma… - Cardiovascular …, 2021 - jacc.org
Objectives This study sought to evaluate the effects of empagliflozin on extracellular volume
(ECV) in individuals with type 2 diabetes mellitus (T2DM) and coronary artery disease …

Cardiac MRI to predict sudden cardiac death risk in dilated cardiomyopathy

Y Li, Y Xu, W Li, J Guo, K Wan, J Wang, Z Xu, Y Han… - Radiology, 2023 - pubs.rsna.org
Background Sudden cardiac death (SCD) is one of the leading causes of death in
individuals with nonischemic dilated cardiomyopathy (DCM). However, the risk stratification …

Impact of late gadolinium-enhanced cardiac MRI on arrhythmic and mortality outcomes in nonischemic dilated cardiomyopathy: updated systematic review and meta …

N Theerasuwipakorn, R Chokesuwattanaskul… - Scientific Reports, 2023 - nature.com
Risk stratification based mainly on the impairment of left ventricular ejection fraction has
limited performance in patients with nonischemic dilated cardiomyopathy (NIDCM) …

Extracellular volume associates with outcomes more strongly than native or post-contrast myocardial T1

TA Treibel, Y Fridman, P Bering, A Sayeed… - Cardiovascular …, 2020 - jacc.org
Objectives Because risk stratification data represents a key domain of biomarker validation,
we compared associations between outcomes and various cardiovascular magnetic …